CTOs on the Move

Diversified Clinical Services

www.diversifiedclinicalservices.com

 
Diversified Clinical Services is a privately held corporation headquartered in Jacksonville, Florida, with offices in Tustin, CA and the Woodlands, TX. The company was formed as a result of a merger between Diversified Therapy and Praxis Clinical
  • Number of Employees: 1K-5K
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Villa San Ramon

Villa San Ramon is a San Ramon, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ProCare Rx

ProCare Rx is a Duluth, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dimension Therapeutics

Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.

Prairie Health Ventures

Prairie Health Ventures is a Lincoln, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Integrated Diagnostics

At Indi we believe that a systems-based approach is necessary to understand complex diseases and improve health. Our mission is to dramatically improve diagnosis and management of complex diseases by building advanced molecular diagnostics and creating new diagnostic technologies. We seek to understand the complex biological systems from which diseases arise so that we can determine which combinations of biomarkers have the greatest diagnostic power. Then we build assays capable of measuring hundreds of proteins at a time, for more precise detection and management of disease. Our end goal is to create large-scale systems medicine diagnostics that can gather a wealth of information – and then make sense of that information so that physicians can better diagnose disease.